Legal & General Group’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,600
| Closed | -$1.95K | – | 3503 |
|
|
2025
Q1 | $1.95K | Hold |
1,600
| – | – | ﹤0.01% | 3356 |
|
|
2024
Q4 | $3.02K | Hold |
1,600
| – | – | ﹤0.01% | 3368 |
|
|
2024
Q3 | $8.54K | Buy |
1,600
+771
| +93% | +$4.12K | ﹤0.01% | 3299 |
|
|
2024
Q2 | $6.12K | Hold |
829
| – | – | ﹤0.01% | 3362 |
|
|
2024
Q1 | $9.9K | Sell |
829
-1
| -0.1% | -$12 | ﹤0.01% | 3202 |
|
|
2023
Q4 | $6.53K | Hold |
830
| – | – | ﹤0.01% | 3294 |
|
|
2023
Q3 | $3.67K | Sell |
830
-118
| -12% | -$521 | ﹤0.01% | 3379 |
|
|
2023
Q2 | $32.9K | Sell |
948
-2
| -0.2% | -$69 | ﹤0.01% | 2942 |
|
|
2023
Q1 | $20.7K | Buy |
950
+331
| +53% | +$7.22K | ﹤0.01% | 3059 |
|
|
2022
Q4 | $13.4K | Hold |
619
| – | – | ﹤0.01% | 3221 |
|
|
2022
Q3 | $15K | Hold |
619
| – | – | ﹤0.01% | 3268 |
|
|
2022
Q2 | $13K | Hold |
619
| – | – | ﹤0.01% | 3337 |
|
|
2022
Q1 | $22K | Buy |
619
+156
| +34% | +$5.54K | ﹤0.01% | 3215 |
|
|
2021
Q4 | $13K | Hold |
463
| – | – | ﹤0.01% | 3408 |
|
|
2021
Q3 | $20K | Hold |
463
| – | – | ﹤0.01% | 3277 |
|
|
2021
Q2 | $23K | Buy |
+463
| New | +$23K | ﹤0.01% | 3245 |
|